A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists
Clinical trial NCT06834009 · COMPLETED
Trial details
- NCT number
- NCT06834009
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-10
- Primary completion
- 2025-04-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.